Target intelligence / Profile preview

NUS1 pseudogene 2 (NUS1P2)

Target
NUS1P2
Molecular classification
Other (classified as a pseudogene)
01

Overview

NUS1P2 is a pseudogene of the NUS1 gene, which encodes the Nogo-B receptor (NgBR) and functions as a subunit of the cis-prenyltransferase complex involved in protein glycosylation and cholesterol trafficking[1][3][5]. The NUS1P2 pseudogene does not code for a functional protein and there is no evidence to suggest it plays a direct role in biological pathways, disease, or drug targeting. Pseudogenes are typically non-functional DNA segments derived from parental genes, and NUS1P2 is identified as such in genomic databases[1]. NUS1 itself is a functional gene with roles in glycosylation, cholesterol transport, and neurological disease[1][3][5], but NUS1P2 is not considered a therapeutic target, receptor, enzyme, transporter, or otherwise druggable entity. Key Point: NUS1P2 (NUS1 pseudogene 2) is not a valid therapeutic target. If the intent was to refer to the functional NUS1 gene, further clarification is needed. For drug discovery or biomedical research, only the functional NUS1 gene is currently of interest, not its pseudogene derivatives[1][3][5].

Other names
NUS1P2NUS1 pseudogene 2

Beyond the preview

Go deeper on NUS1 pseudogene 2 (NUS1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NUS1 pseudogene 2 (NUS1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call